JP2022507214A5 - - Google Patents
Info
- Publication number
- JP2022507214A5 JP2022507214A5 JP2021525675A JP2021525675A JP2022507214A5 JP 2022507214 A5 JP2022507214 A5 JP 2022507214A5 JP 2021525675 A JP2021525675 A JP 2021525675A JP 2021525675 A JP2021525675 A JP 2021525675A JP 2022507214 A5 JP2022507214 A5 JP 2022507214A5
- Authority
- JP
- Japan
- Prior art keywords
- metal
- ion
- metal complex
- complex according
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023137271A JP2023179429A (ja) | 2018-11-12 | 2023-08-25 | キレート化ａａｚｔａコンジュゲートおよびその錯体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18205796 | 2018-11-12 | ||
| EP18205796.8 | 2018-11-12 | ||
| PCT/EP2019/081014 WO2020099398A1 (en) | 2018-11-12 | 2019-11-12 | Chelating aazta conjugates and complexes thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023137271A Division JP2023179429A (ja) | 2018-11-12 | 2023-08-25 | キレート化ａａｚｔａコンジュゲートおよびその錯体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507214A JP2022507214A (ja) | 2022-01-18 |
| JP2022507214A5 true JP2022507214A5 (enExample) | 2022-11-18 |
| JP7744240B2 JP7744240B2 (ja) | 2025-09-25 |
Family
ID=64308553
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525675A Active JP7744240B2 (ja) | 2018-11-12 | 2019-11-12 | キレート化ａａｚｔａコンジュゲートおよびその錯体 |
| JP2023137271A Pending JP2023179429A (ja) | 2018-11-12 | 2023-08-25 | キレート化ａａｚｔａコンジュゲートおよびその錯体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023137271A Pending JP2023179429A (ja) | 2018-11-12 | 2023-08-25 | キレート化ａａｚｔａコンジュゲートおよびその錯体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11684682B2 (enExample) |
| EP (1) | EP3880635B1 (enExample) |
| JP (2) | JP7744240B2 (enExample) |
| CN (1) | CN112996764B (enExample) |
| WO (1) | WO2020099398A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3880635B1 (en) * | 2018-11-12 | 2023-01-04 | Bracco Imaging SPA | Chelating aazta conjugate, complexes thereof and use |
| US11541134B1 (en) | 2021-08-02 | 2023-01-03 | Rayzebio, Inc. | Stabilized compositions of radionuclides and uses thereof |
| JP2025524769A (ja) | 2022-07-28 | 2025-08-01 | ブラッコ・イメージング・ソシエタ・ペル・アチオニ | ２，４，６－トリヨードフェノール誘導体の製造方法 |
| WO2025120059A1 (en) | 2023-12-06 | 2025-06-12 | Bracco Imaging Spa | Compound for disorders associated with excess and/or accumulation of iron ions |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7893223B2 (en) * | 2001-07-17 | 2011-02-22 | Bracco Imaging S.P.A. | Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| ITMI20011518A1 (it) | 2001-07-17 | 2003-01-17 | Bracco Imaging Spa | Leganti azotati multidentati capaci di complessare ioni metallici e loro uso in diagnostica e in terapia |
| CN1993357B (zh) | 2004-07-02 | 2011-10-19 | 伯拉考成像股份公司 | 用于磁共振成像(mri)的含有具有多羟基化取代基的螯合部分的高弛豫造影剂 |
| EP2097438B1 (en) * | 2006-12-11 | 2015-08-26 | Bracco Imaging S.p.A | Fibrin binding peptide conjugates for diagnostic and therapeutic applications |
| EP1964846A1 (en) * | 2007-02-27 | 2008-09-03 | Bracco Imaging, S.P.A. | Process for the preparation of contrast agents |
| FR2914304B1 (fr) | 2007-03-28 | 2012-11-16 | Guerbet Sa | Composes pour le diagnostic de maladies liees a l'expression de vcam. |
| EP2639227A1 (en) | 2012-03-14 | 2013-09-18 | Bracco Imaging S.p.A | A new class of diazepine derivative chelating agents and complexes with paramagnetic metals as MRI contrast agents |
| EP3177598B1 (en) * | 2014-07-28 | 2019-08-28 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Macrocyclic complexes, their process of preparation and use as pet imaging agents |
| DE102014115154A1 (de) * | 2014-10-17 | 2016-04-21 | SCV-SpezialChemikalien-Vertrieb GmbH | Konjugierte Bisphosphonate für die Diagnostik und Therapie von Knochenerkrankungen |
| HK1259311A1 (zh) | 2015-10-28 | 2019-11-29 | Tva (Abc), Llc | Sstr靶向綴合物及其顆粒和製劑 |
| EP3880635B1 (en) * | 2018-11-12 | 2023-01-04 | Bracco Imaging SPA | Chelating aazta conjugate, complexes thereof and use |
| CN213135750U (zh) * | 2020-08-28 | 2021-05-07 | 苏州信毅捷自动化科技有限公司 | 一种便于拆卸的曲柄压装设备 |
-
2019
- 2019-11-12 EP EP19801028.2A patent/EP3880635B1/en active Active
- 2019-11-12 CN CN201980074119.4A patent/CN112996764B/zh active Active
- 2019-11-12 JP JP2021525675A patent/JP7744240B2/ja active Active
- 2019-11-12 WO PCT/EP2019/081014 patent/WO2020099398A1/en not_active Ceased
- 2019-11-12 US US17/292,479 patent/US11684682B2/en active Active
-
2023
- 2023-08-25 JP JP2023137271A patent/JP2023179429A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11707539B2 (en) | FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto | |
| ES2593127T5 (es) | Proceso para preparar una formulación farmacéutica de agentes de contraste | |
| US10500292B2 (en) | PSMA-binding agents and uses thereof | |
| JP2017121233A5 (enExample) | ||
| EP3634499A1 (en) | Cd206+ macrophage-specific molecular imaging probe compositions and methods and the noninvasive quantification of arterial wall macrophage infiltration in humans | |
| JP2010512369A5 (enExample) | ||
| JP2010523599A5 (enExample) | ||
| Rossetti et al. | Human biodistribution, dosimetry and clinical use of technetium (III)-99m-Q12 | |
| EP3383385B2 (en) | Melflufen dosage regimens for cancer | |
| JP2021521209A (ja) | 鉄過剰症の治療のための組成物及び方法 | |
| US20080138440A1 (en) | Methods of diagnosing and alleviating gadolinium toxicity | |
| JP2021502358A5 (enExample) | ||
| JP2018502150A5 (enExample) | ||
| JP2023062146A (ja) | アスタチン溶液及びその製造方法 | |
| JP2015514689A5 (enExample) | ||
| CN117677405A (zh) | 具有较高吸收率的靶向系统 | |
| JP7802851B2 (ja) | 放射性標識されたｇｐｒｐアンタゴニスト及び界面活性剤を含む医薬組成物 | |
| JP2021185141A (ja) | サルコイドーシスを処置するための１，３−プロパンジスルホン酸またはその薬学的に許容される塩の使用 | |
| WO2009108868A2 (en) | Radiolabeled hedgehog derivatives for imaging and therapy | |
| Minutoli et al. | Combined use of peptide receptor radionuclide therapy and metronomic chemotherapy in neuroendocrine tumors: a possible choice driven by nuclear medicine molecular imaging | |
| US20240207292A1 (en) | Boronic acid compounds, compositions and methods | |
| KR20260057408A (ko) | 신경내분비암의 진단 및/또는 치료 방법 | |
| JP2025535957A (ja) | がんの特定および／または治療 | |
| US20250387523A1 (en) | Combination therapy of radionuclide complex | |
| IL325208A (en) | Radiolabeled compound for use in a method of treating carbonic anhydrase positive diseases ix |